
Meta-regression coefficients, by drug class, S1 - SGLTi1/2
======================================================================================
                      Outcome               Class    Slope    CI.lb    CI.ub   P-value
--------------------------------------------------------------------------------------
5               All-cause Mortality        GLP-1RA    0.13    -4.381   4.641    0.955 
1            Cardiovascular Mortality      GLP-1RA   0.782    -3.513   5.078    0.721 
2                      MACE                GLP-1RA   0.971    -3.487   5.428    0.67  
6              Myocardial Infarction       GLP-1RA   1.361    -3.291   6.013    0.566 
7                     Stroke               GLP-1RA   -0.774   -4.68    3.133    0.698 
3        Hospitalization for Heart Failure GLP-1RA   1.297    -2.504   5.099    0.504 
4             Composite Renal Outcome      GLP-1RA   -0.945   -7.429   5.539    0.775 
12              All-cause Mortality         SGLT2i   0.328    -0.23    0.886    0.249 
8            Cardiovascular Mortality       SGLT2i   0.536    -0.052   1.124    0.074 
9                      MACE                 SGLT2i   1.151    -1.16    3.463    0.329 
13             Myocardial Infarction        SGLT2i   -0.15    -2.785   2.485    0.911 
14                    Stroke                SGLT2i   -0.081   -2.906   2.745    0.955 
10       Hospitalization for Heart Failure  SGLT2i   1.444    1.047    1.842      0   
11            Composite Renal Outcome       SGLT2i   0.297    -0.408   1.002    0.409 
--------------------------------------------------------------------------------------
Absolute risk difference and baseline cardiovascular mortality rate. Sensitivity      
